Use of Dupilumab Reduced Endoscopic Sinus Surgery in Patients with Chronic Rhinosinusitis with Nasal Polyps

Dupilumab Leads to Improved Quality-of-Life in Patients with Chronic Rhinosinusitis with Nasal Polyps

Use of Multiple Concurrent Biologic Therapies: A Potential New Treatment Option for Patients with Refractory CRSwNP and Asthma

Dupilumab Shows Promising Results in Improving Health-Related Quality of Life for Patients with Chronic Rhinosinusitis with Nasal Polyps

Dupilumab is Effective in Decreasing Symptoms of Severe Chronic Rhinosinusitis

Relief of Asthma and Chronic Rhinosinusitis in Patients Over 65 Years of Age Treated with Dupilumab

Evaluating Prevalence of Cognitive Dysfunction in Patients with Chronic Rhinosinusitis

Medication Compliance Ensures Greater Surgical Success in Cases of Fungal Sinusitis of the Frontal Sinus

Price Variation of Common Outpatient Rhinology Procedures

Social Media Perceptions on The Rhinology Industry

×
Advertisement